Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ValiRx PLC (GB:VAL)
LSE:VAL
Holding GB:VAL?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 10, 2024 | Mark Eccleston Chief Executive Officer, >10% Owner | xxxxxxxxxxxxx | £20000 |
| Dec 09, 2024 | Mark Eccleston Chief Executive Officer, >10% Owner | xxxxxxxxxxxxx | £115000 |
| Dec 09, 2024 | Gerry Desler Chief Financial Officer | xxxxxxxxxxxxx | £5000 |
| Dec 09, 2024 | Catherine Tralau Stewart Chief Scientific Officer | xxxxxxxxxxxxx | £5000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns ValiRx PLC (GB:VAL)?
Currently, no data Available
What percentage of ValiRx PLC (GB:VAL) stock is held by institutional investors?
Currently, no data Available
What percentage of ValiRx PLC (GB:VAL) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of ValiRx PLC (GB:VAL)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.